1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC4372 |
Quality Control | All cell lots test negative for HIV-1, HBV, HCV, mycoplasma, yeast, fungi, and other pathogens. |
Product Category | Primary Cells |
Size/Quantity | 1M |
Cell Type | Eosinophil |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Immune Cells |
Key Features | – Backed by AcceGen advanced technology – Cryopreserved for highest viability and plating efficiency – Quality-guaranteed for accurate results – Timely technical support for best experimental outcomes |
Human CD16-/CD66b+ Eosinophils-Negatively Selected are primary granulocytes isolated from peripheral blood, enriched for eosinophils and depleted of other cell types. These eosinophils play a critical role in immune defense against parasitic, bacterial, and viral infections, as well as in allergic inflammatory responses like asthma. They exhibit bilobed nuclei and cytotoxic granules containing proteins like eosinophil peroxidase and major basic protein (MBP). CD66b, a surface protein highly expressed on these eosinophils, regulates their adhesion and activation during immune responses. The cells are cryopreserved at early passage and cannot proliferate or be passaged. Repeated freeze-thaw cycles should be avoided to maintain their functionality and viability.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human CD16-/CD66b+ eosinophils serve as an accessible model for studying the biology and pathophysiology of eosinophils.. Eosinophils are implicated in a range of diseases, including asthma, eosinophilic gastrointestinal (GI) disorders, and hypereosinophilic syndrome. Further investigation targeting eosinophils could offer valuable insights into treatments for eosinophil-associated diseases..